en.unionpedia.org

Dotinurad, the Glossary

Dotinurad (Urece) is a drug for the treatment of gout and hyperuricemia.^[1]

8 relations: Benzbromarone, Drug development, Fortress Biotech, Gout, Hyperuricemia, Pharmaceuticals and Medical Devices Agency, SLC22A12, Uric acid.
Antigout agents
Benzothiazoles

Benzbromarone

Benzbromarone is a uricosuric agent and non-competitive inhibitor of xanthine oxidase used in the treatment of gout, especially when allopurinol, a first-line treatment, fails or produces intolerable adverse effects. Dotinurad and Benzbromarone are Antigout agents.

See Dotinurad and Benzbromarone

Drug development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.

See Dotinurad and Drug development

Fortress Biotech

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products.

See Dotinurad and Fortress Biotech

Gout

Gout is a form of inflammatory arthritis characterized by recurrent attacks of pain in a red, tender, hot, and swollen joint, caused by the deposition of needle-like crystals of uric acid known as monosodium urate crystals.

See Dotinurad and Gout

Hyperuricemia

Hyperuricaemia or hyperuricemia is an abnormally high level of uric acid in the blood.

See Dotinurad and Hyperuricemia

Pharmaceuticals and Medical Devices Agency

The (PhMDA) is an Independent Administrative Institution responsible for ensuring the safety, efficacy and quality of pharmaceuticals and medical devices in Japan.

See Dotinurad and Pharmaceuticals and Medical Devices Agency

SLC22A12

Solute carrier family 22 (organic anion/cation transporter), member 12, also known as SLC22A12 and URAT1, is a protein which in humans is encoded by the SLC22A12 gene.

See Dotinurad and SLC22A12